0000912061-20-000025.txt : 20200506 0000912061-20-000025.hdr.sgml : 20200506 20200506090313 ACCESSION NUMBER: 0000912061-20-000025 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20200506 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL HEALTH TRENDS CORP CENTRAL INDEX KEY: 0000912061 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 592705336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36849 FILM NUMBER: 20851402 BUSINESS ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 BUSINESS PHONE: 852-3107-0800 MAIL ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 8-K 1 nhtc-20200506.htm 8-K nhtc-20200506
0000912061false00009120612020-05-062020-05-06

UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
May 6, 2020
Date of Report (Date of earliest event reported)
 NATURAL HEALTH TRENDS CORP.
(Exact name of registrant as specified in its charter)
Delaware001-3684959-2705336
(State or other jurisdiction of incorporation)        (Commission File Number)  (IRS Employer Identification No.)

 Units 1205-07, 12F, Mira Place Tower A, 132 Nathan Road, Tsimshatsui, Kowloon, Hong Kong
(Address of principal executive offices, including zip code)

+852-3107-0800
(Registrant’s telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

   Emerging growth company

o    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareNHTCThe NASDAQ Stock Market LLC




Item 2.02 Results of Operations and Financial Condition.
 
On May 6, 2020, Natural Health Trends Corp. issued an earnings release announcing its results for the quarter ended March 31, 2020. The press release is attached hereto as exhibit 99.1.
 
Item 9.01 Financial Statements and Exhibits.
 
(d)Exhibits.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: May 6, 2020
 NATURAL HEALTH TRENDS CORP.
   
   
 By:/s/ Timothy S. Davidson                                                     
  Timothy S. Davidson
  Senior Vice President and Chief Financial Officer


EX-99.1 2 q12020nhtcearningsrele.htm EX-99.1 Document

Exhibit 99.1

Natural Health Trends Reports First Quarter 2020 Financial Results

Strong balance sheet with ample liquidity and $95 million in cash and cash equivalents
Declared a quarterly cash dividend of $0.20 per share
Expect to realize $8 million in annualized cost savings in 2020

HONG KONG – May 6, 2020 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the first quarter ended March 31, 2020.

First Quarter 2020 Financial Highlights

Revenue of $14.9 million decreased 23% compared to $19.3 million in the first quarter of 2019.
Operating loss was $1.4 million compared to a loss of $2.7 million in the first quarter of 2019.
Net loss was $573,000, or $0.05 per diluted share, compared to a net loss of $1.9 million, or $0.17 per diluted share, in the first quarter of 2019.
The number of Active Members1 decreased 2% to 56,490 at March 31, 2020 compared to 57,410 at December 31, 2019, and decreased 35% compared to 87,340 at March 31, 2019.
1Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

Management Commentary

“First and foremost, our thoughts are with all of those around the world who have been impacted by the coronavirus,” commented Chris Sharng, President of Natural Health Trends Corp. “I am pleased that we have continued to run our operations efficiently with the health and safety of our employees, members and customers guiding our decisions as our top priority. The impact of the pandemic followed the already difficult operating conditions we experienced throughout 2019. While we could have never foreseen the impact COVID-19 would have on the global economy, we focused our efforts in 2019 on preparing our business to adapt to new realities following China’s 100-day campaign and have been applying key learnings from our experience to support our affected markets. To that end, we started implementing aggressive cost reduction measures beginning in the second half of 2019 which were partially offset by additional spending during the first quarter in direct response to COVID-19 and the governments’ measures to control the spread of the virus. As a result of the net effect of these actions, we narrowed the scope of our first quarter operating loss and decline in cash flow from operations despite the fact that our main markets were under severe lockdown for most of first quarter of 2020.”

Mr. Sharng concluded, “We have ample liquidity with $95 million in cash and cash equivalents and zero debt. Further, our highly variable cost structure allows us the flexibility to adapt in-line with order volume. As previously announced, we put a program in place to position us for increased operating efficiencies in several areas including reducing headcount and promotional spending. As a result, we now expect to realize annualized cost savings of approximately $8 million in 2020. I feel confident our employees and members will work together through these unprecedented times with our support and that we will emerge from this downturn even stronger than before.”
1



Balance Sheet and Cash Flow

Net cash used in operating activities was $990,000 in the first quarter of 2020, compared to $11.3 million in the first quarter of 2019.
Total cash and cash equivalents were $95.4 million at March 31, 2020, down slightly from $96.0 million at December 31, 2019.
On May 4, 2020, the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on May 29, 2020 to stockholders of record as of May 19, 2020.

First Quarter 2020 Financial Results Conference Call

Management will host a conference call to discuss the first quarter 2020 financial results today, Wednesday, May 6, 2020 at 11:30 a.m. Eastern Time. The conference call details are as follows:
Date:
Wednesday, May 6, 2020
Time:
11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
Dial-in:
1-877-407-0789 (Domestic)
1-201-689-8562 (International)
Conference ID:
13700943
Webcast:
http://public.viavid.com/index.php?id=138751

For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on May 6, 2020 through 11:59 p.m. Eastern Time on May 20, 2020 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13700943.

About Natural Health Trends Corp.

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on March 9, 2020 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

2


CONTACTS:

Company Contact:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (Hong Kong): +852-3107-0800
Tel (U.S.): 310-541-0888
scott.davidson@nhtglobal.com
Investor Contact:
ADDO Investor Relations
Tel: 310-829-5400
investor.relations@nhtglobal.com
3


NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data) 

 March 31, 2020December 31, 2019
 (Unaudited) 
ASSETS  
Current assets:  
Cash and cash equivalents$95,393  $96,035  
Inventories5,406  6,404  
Other current assets6,922  5,936  
Total current assets107,721  108,375  
Property and equipment, net649  735  
Operating lease right-of-use assets2,878  3,135  
Restricted cash505  3,390  
Deferred tax asset1,162  2,039  
Other assets754  823  
Total assets$113,669  $118,497  
LIABILITIES AND STOCKHOLDERS’ EQUITY  
Current liabilities:  
Accounts payable$848  $680  
Accrued commissions2,341  2,931  
Other accrued expenses1,971  2,387  
Deferred revenue3,994  4,506  
Amounts held in eWallets12,823  12,938  
Operating lease liabilities1,549  1,655  
Other current liabilities1,275  1,205  
Total current liabilities24,801  26,302  
Income taxes payable15,365  15,365  
Deferred tax liability203  202  
Operating lease liabilities1,403  1,564  
Total liabilities41,772  43,433  
Stockholders’ equity:  
Preferred stock—  —  
Common stock13  13  
Additional paid-in capital86,102  86,102  
Retained earnings13,259  16,117  
Accumulated other comprehensive loss(1,573) (1,264) 
Treasury stock, at cost(25,904) (25,904) 
Total stockholders’ equity71,897  75,064  
Total liabilities and stockholders’ equity$113,669  $118,497  

4


NATURAL HEALTH TRENDS CORP. 
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)
 
 Three Months Ended March 31,
 20202019
Net sales$14,948  $19,328  
Cost of sales4,514  5,224  
Gross profit10,434  14,104  
Operating expenses:  
Commissions expense6,603  9,498  
Selling, general and administrative expenses5,279  7,315  
Total operating expenses11,882  16,813  
Loss from operations(1,448) (2,709) 
Other income, net93  432  
Loss before income taxes(1,355) (2,277) 
Income tax benefit(782) (354) 
Net loss$(573) $(1,923) 
Net loss per common share – basic and diluted$(0.05) $(0.17) 
Weighted-average common shares outstanding – basic and diluted10,483  11,333  

5


NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
 
 Three Months Ended March 31,
 20202019
CASH FLOWS FROM OPERATING ACTIVITIES: 
Net loss$(573) $(1,923) 
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization95  93  
Noncash lease expense418  447  
Deferred income taxes869  —  
Changes in assets and liabilities:
Inventories1,001  (192) 
Other current assets(1,033) (1,159) 
Other assets52  (2) 
Accounts payable168  (174) 
Accrued commissions(528) (3,575) 
Other accrued expenses(398) (795) 
Deferred revenue(521) (3,030) 
Amounts held in eWallets(175) (142) 
Operating lease liabilities(440) (499) 
Other current liabilities75  (241) 
Long-term incentive—  (158) 
Net cash used in operating activities(990) (11,350) 
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment(12) (46) 
Net cash used in investing activities(12) (46) 
CASH FLOWS FROM FINANCING ACTIVITIES:
Dividends paid(2,285) (2,736) 
Net cash used in financing activities(2,285) (2,736) 
Effect of exchange rates on cash, cash equivalents and restricted cash(240) 248  
Net decrease in cash, cash equivalents and restricted cash(3,527) (13,884) 
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period99,425  135,651  
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period$95,898  $121,767  
SUPPLEMENTAL DISCLOSURES OF OTHER CASH FLOW INFORMATION:  
Issuance of treasury stock for employee awards, net$—  $377  
Right-of-use assets obtained in exchange for operating lease liabilities$194  $4,462  

6
EX-101.SCH 3 nhtc-20200506.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 nhtc-20200506_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 nhtc-20200506_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 nhtc-20200506_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name Entity Address, Address Line Two Entity Address, Address Line Two City Area Code City Area Code Entity Address, Country Entity Address, Country Entity Address, Address Line Three Entity Address, Address Line Three Cover page. Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 nhtc-20200506_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 nhtc-20200506_htm.xml IDEA: XBRL DOCUMENT 0000912061 2020-05-06 2020-05-06 0000912061 false 8-K 2020-05-06 NATURAL HEALTH TRENDS CORP. DE 001-36849 59-2705336 Units 1205-07, 12F Mira Place Tower A 132 Nathan Road Tsimshatsui HK 852 3107-0800 false false false false false Common Stock, par value $0.001 per share NHTC NASDAQ XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.naturalhealthtrendscorp.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports nhtc-20200506.htm nhtc-20200506.xsd nhtc-20200506_cal.xml nhtc-20200506_def.xml nhtc-20200506_lab.xml nhtc-20200506_pre.xml q12020nhtcearningsrele.htm http://xbrl.sec.gov/dei/2019-01-31 true true XML 10 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Cover Page
May 06, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 06, 2020
Entity Registrant Name NATURAL HEALTH TRENDS CORP.
Entity Incorporation, State or Country Code DE
Entity File Number 001-36849
Entity Tax Identification Number 59-2705336
Entity Address, Address Line One Units 1205-07, 12F
Entity Address, Address Line Two Mira Place Tower A
Entity Address, Address Line Three 132 Nathan Road
Entity Address, City or Town Tsimshatsui
Entity Address, Country HK
City Area Code 852
Local Phone Number 3107-0800
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol NHTC
Security Exchange Name NASDAQ
Entity Central Index Key 0000912061
Amendment Flag false
ZIP 11 0000912061-20-000025-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000912061-20-000025-xbrl.zip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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 14 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nhtc-20200506.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "nhtc-20200506_cal.xml" ] }, "definitionLink": { "local": [ "nhtc-20200506_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "nhtc-20200506.htm" ] }, "labelLink": { "local": [ "nhtc-20200506_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "nhtc-20200506_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "nhtc-20200506.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nhtc", "nsuri": "http://www.naturalhealthtrendscorp.com/20200506", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nhtc-20200506.htm", "contextRef": "i0eeef979aac44c38a948f7aaf83b6147_D20200506-20200506", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.naturalhealthtrendscorp.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nhtc-20200506.htm", "contextRef": "i0eeef979aac44c38a948f7aaf83b6147_D20200506-20200506", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" }